JPMorgan Securities Plc AbbVie Inc 38.5a

Date : 26/03/2020 @ 11:25
Source : UK Regulatory (RNS & others)

JPMorgan Securities Plc AbbVie Inc 38.5a

TIDMTTM

RNS Number : 7224H

JPMorgan Securities Plc

26 March 2020

Ap24

   FORM   38.5(a) 
   IRISH  TAKEOVER   PANEL 
   DISCLOSURE UNDER RULE 38.5(a) OF THE IRISH  TAKEOVER   PANEL ACT,  1997,  TAKEOVER  RULES, 2013 

DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS WITH RECOGNISED INTERMEDIARY STATUS AND DEALING IN A

   CLIENT-SERVING   CAPACITY 
   1.       KEY   INFORMATION 
 
Name of exempt principal    J.P. Morgan Securities 
 trader                      Plc 
Company dealt in            AbbVie Inc. 
                            ====================== 
Class of relevant security  Common stock 
 to which the dealings 
 being disclosed relate 
 (Note 1) 
                            ====================== 
Date of dealing             25 March 2020 
                            ====================== 
 
   2.        DEALINGS  (Note   2) 
   (a)      Purchases and sales 
 
     Total number             Highest price paid     Lowest price 
      of relevant                  (Note 3)              paid 
  securities acquired                                  (Note 3) 
       15,038                 69.7400 USD           67.7100 USD 
                       =========================  =============== 
 
 
  Total number          Highest price received     Lowest price 
  of securities                (Note 3)              received 
    disposed                                         (Note 3) 
       -                       -                       - 
                 =============================  =============== 
 
   (b)      Derivatives transactions (other than options transactions) 
 
  Product     Nature of transaction   Number of relevant   Price per 
    name,            (Note 4)             securities          unit 
  e.g. CFD                                 (Note 5)         (Note 3) 
Equity Swap 
             ======================  ===================  ========== 
 

Ap25

   (c)      Options transactions in respect of existing relevant securities 
   (i)       Writing,   selling, purchasing or varying 
 
  Product       Writing,      Number of      Exercise        Type,       Expiry          Option 
    name,       selling,      securities       price     e.g. American,   date     money paid/received 
  e.g. call    purchasing,     to which                     European                    per unit 
   option        varying      the option                      etc.                      (Note 3) 
                  etc.       relates (Note 
                                  5) 
 
 
   (ii)      Exercising 
 
Product name,             Number of securities      Exercise price 
 e.g. call option                                    per unit (Note 
                                                     3) 
 
 
   3.      OTHER  INFORMATION 

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other

person   relating   to   the   voting   rights   of   any   relevant   securities 

under any option referred to on this form or relating to the voting rights or future acquisition

or disposal of any relevant securities to which any derivative referred to on this form is referenced.

   If   none,   this   should   be   stated. 
 
Date of disclosure           26 March 2020 
Contact name                 Alwyn Basch 
                             ============================= 
Telephone number             020 7742 7407 
                             ============================= 
Name of offeree/offeror      Allergan plc 
 with which connected 
                             ============================= 
Nature of connection (Note   Financial Advisor to Allergan 
 6)                           plc 
                             ============================= 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

ISEKKABBDBKDBNB

(END) Dow Jones Newswires

March 26, 2020 07:25 ET (11:25 GMT)

$
ADVFN Advertorial
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20200329 09:04:25